Adenocarcinoma of endometrium involving adenomyosis. Report of an unusual case and review of the literature

Case report OA: closed CC0 ⤵ 22 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This report presents a case of adenocarcinoma originating in both endometrial and adenomyotic epithelium, concluding that malignant transformation occurred within a susceptible field that encompassed both tissue types.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A case of adenocarcinoma developing in endometrial and adenomyotic epithelium is presented. The pattern of development of the carcinoma is discussed in relation to the histogenesis of adenomyosis. The authors conclude that the malignant transformation occurred in a susceptible field that included both endometrial and adenomyotic epithelium. The rare examples of adenocarcinoma arising in and confined solely to adenomyosis represent limit cases. The possible effect of estrogen is reviewed.

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosis

MeSH descriptors

Endometriosis Endometriosis Estrogens Uterine Neoplasms Adenocarcinoma Adenocarcinoma Adenocarcinoma Endometriosis Endometriosis Estrogens Estrogens Female Female Humans Humans Middle Aged Middle Aged Uterine Neoplasms Uterine Neoplasms

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (41)

Cited by (22)

Source provenance

europepmc
last seen: 2026-10-11T09:27:45.537177+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:57:58.406719+00:00
License: CC0 · commercial use OK